A real-world prospective analysis of the relationship between nanoliposomal irinotecan and fluorouracil with folinic acid and neutropenia in patients with pancreatic cancer (NAPOLEON-2 study, NN-2401).

被引：0
|
作者：
Shirakawa, Tsuyoshi
Araki, Tomonori
Shimokawa, Mototsugu
Otsuka, Taiga
Nakazawa, Junichi
Shimokawa, Hozumi
Koga, Futa
Oda, Hisanobu
Takeshita, Shigeyuki
Arima, Shiho
Arita, Shuji
Kawaguchi, Yasunori
Nishikawa, Kazuo
Taguchi, Hiroki
Jikuya, Kenichi
Sakai, Tatsunori
Ueda, Yujiro
Sakae, Takahiro
Mizuta, Toshihiko
Mitsugi, Kenji
机构：
[1] Clin Hematol Oncol Treatment Study Grp, Fukuoka, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Biostat, Yamaguchi, Japan
[4] Minato Med Clin, Tokyo, Japan
[5] Kagoshima City Hosp, Kagoshima, Japan
[6] Japan Community Healthcare Org, Kitakyushu, Fukuoka, Japan
[7] Saga Med Ctr Koseikan, Saga, Japan
[8] Saiseikai Kumamoto Hosp, Kumamoto, Japan
[9] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan
[10] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Japan
[11] Miyazaki Prefectural Miyazaki Hosp, Miyazaki, Japan
[12] Asakura Med Assoc Hosp, Asakura, Japan
[13] Oita Univ, Fac Med, Yufu, Japan
[14] Imakiire Gen Hosp, Kagoshima, Japan
[15] Natl Hosp Org, Kumamoto, Japan
[16] Japanese Red Cross Kumamoto Hosp, Kumamoto, Japan
[17] Saiseikai Sendai Hosp, Satsumasendai, Japan
[18] Fujikawa Hosp, Saga, Japan
[19] Sasebo Kyosai Hosp, Sasebo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：762 / 762
页数：1
相关论文
共 27 条
  • [21] A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).
    Hendifar, Andrew Eugene
    Kim, Sungjin
    Tighiouart, Mourad
    Hautamaki, Emily
    Kim, Haesoo
    Ng, Camille
    Liu, Jar-Yee
    Scher, Kevin S.
    Klempner, Samuel J.
    Placencio-Hickok, Veronica
    Gresham, Gillian
    Gong, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
    Yoo, Changhoon
    Im, Hyeon-Su
    Kim, Kyu-pyo
    Oh, Do-Youn
    Lee, Kyung-Hun
    Chon, Hong Jae
    Kim, Joo Hoon
    Kang, Myoungjoo
    Kim, Ilhwan
    Lee, Guk Jin
    Oh, Sung Yong
    Choi, Younak
    Choi, Hye Jin
    Kim, Seung Tae
    Park, Joon Oh
    Ryoo, Baek-Yeol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [23] Observational retrospective evaluation of treatment with liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic cancer patients: An Italian large real-world analysis
    Pellino, Antonio
    Manai, Chiara
    Merz, Valeria
    Scartozzi, Mario
    Milella, Michele
    De Vita, Ferdinando
    Antonuzzo, Lorenzo
    Zichi, Clizia
    Satolli, Maria Antonietta
    Panebianco, Michele
    Noventa, Silvia
    Giordano, Guido
    Nappo, Floriana
    Zecchetto, Camilla
    Puzzoni, Marco
    Vaccaro, Vanja
    Pappalardo, Annalisa
    Giommoni, Elisa
    Melisi, Davide
    Lonardi, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [24] Irinotecan liposome-based regimen in Chinese patients with advanced pancreatic cancer: A prospective, multi-center, observational real-world study
    Xu, J.
    Jiang, K.
    Lu, H.
    Gong, X.
    Li, H.
    Wu, Y.
    Chen, L.
    Liu, W.
    Wu, D.
    Du, J.
    Sun, L.
    Zhao, Y.
    Dai, E.
    An, H.
    Liu, Y.
    Wang, X.
    Liu, Q.
    Yu, X.
    ANNALS OF ONCOLOGY, 2024, 35 : S1500 - S1500
  • [25] Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)
    Koga, Futa
    Kawaguchi, Yasunori
    Shimokawa, Mototsugu
    Murayama, Kenichiro
    Nakashita, Shunya
    Oza, Noriko
    Ureshino, Norio
    Takahashi, Hirokazu
    Ueda, Yujiro
    Nakazawa, Junichi
    Komori, Azusa
    Otsu, Satoshi
    Arima, Shiho
    Fukahori, Masaru
    Makiyama, Akitaka
    Taguchi, Hiroki
    Honda, Takuya
    Shibuki, Taro
    Nio, Kenta
    Ide, Yasushi
    Mizuta, Toshihiko
    Shirakawa, Tsuyoshi
    Otsuka, Taiga
    Mitsugi, Kenji
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (01) : 82 - 87
  • [26] Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies
    Araki, Tomonori
    Kawahira, Machiko
    Shimokawa, Mototsugu
    Otsuka, Taiga
    Hayashi, Kohei
    Sonoda, Yuki
    Honda, Takuya
    Nakao, Kazuhiko
    Shibuki, Taro
    Nakazawa, Junichi
    Arima, Shiho
    Fukahori, Masaru
    Miwa, Keisuke
    Koga, Futa
    Ueda, Yujiro
    Kubotsu, Yoshihito
    Makiyama, Akitaka
    Shimokawa, Hozumi
    Takeshita, Shigeyuki
    Nishikawa, Kazuo
    Komori, Azusa
    Otsu, Satoshi
    Hosokawa, Ayumu
    Sakai, Tatsunori
    Oda, Hisanobu
    Arita, Shuji
    Taguchi, Hiroki
    Tsuneyoshi, Kengo
    Kawaguchi, Yasunori
    Fujita, Toshihiro
    Sakae, Takahiro
    Nio, Kenta
    Ide, Yasushi
    Ureshino, Norio
    Shirakawa, Tsuyoshi
    Mizuta, Toshihiko
    Mitsugi, Kenji
    ONCOLOGY, 2024,
  • [27] Impact of the introduction of CDK4/6 inhibitors on treatment duration in patients with HR+, HER2-advanced breast cancer: Final analysis of TreatER plus ight, a Canadian prospective, real-world, observational study
    Doyle, Catherine
    Lohmann, Ana Elisa
    Iqbal, Nayyer
    Henning, Jan-Willem
    Kulkarni, Swati
    Califaretti, Nadia
    Hilton, John
    Ferrario, Cristiano
    Bouganim, Nathaniel
    Mates, Mihaela
    Guillemette, Stephanie
    Leite, Ricardo
    Chia, Stephen
    CANCER RESEARCH, 2024, 84 (09)
123